Parkinson's disease progresses to stages where oral treatments become insufficient. While continuous subcutaneous foslevodopa/foscarbidopa (fLD/fCD), a less invasive option, improves motor control, yet little is known about patients and caregivers experiences. This phenomenological study explores th...
Advanced Neuroscience Nursing PracticeOral Presentation